Royal Bank of Canada »

Akero Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $573k 12k 48.21
2025-06-30 $915k 17k 54.71
2025-03-31 $1.1M 27k 42.55
2024-12-31 $649k 23k 27.81
2024-09-30 $663k 23k 28.69
2024-06-30 $550k 23k 24.05
2024-03-31 $402k 18k 22.99
2023-12-31 $706k 30k 23.23
2023-09-30 $812k 19k 43.48
2023-06-30 $228k 4.9k 47.00
2022-12-31 $531k 5.3k 100.00
2022-09-30 $88k 2.6k 33.91
2021-06-30 $99k 4.0k 24.86
2021-03-31 $96k 3.3k 29.52
2020-12-31 $70k 1.8k 38.46
2020-09-30 $34k 1.1k 31.16
2020-06-30 $27k 1.1k 24.75
2020-03-31 $23k 1.1k 20.41
2019-12-31 $17k 744 22.85
2019-09-30 $1.0k 44 22.73